COP - CIK 0001163165
The table below shows CONOCOPHILLIPS's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $19.80B | $20.12B | $19.96B | $28.31B | $17.00B | $4.80B |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$8.84B | -$11.15B | -$12.00B | -$8.74B | -$8.54B | -$4.12B |
| Dividends paid | $4.00B | $3.65B | $5.58B | $5.73B | $2.36B | $1.83B |
CONOCOPHILLIPS reported operating cash flow of $19.80B for fiscal year 2025. That is down 1.6% from $20.12B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $4.40B (FY 2016) to $19.80B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $5.02B | $5.46B | $5.40B | $9.27B | $3.62B | $892.00M |
| Financing cash flow | -$10.10B | -$8.84B | -$8.66B | -$18.05B | -$6.33B | -$2.71B |